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ABSTRACT
Pediatric asthma is the most prevalent chronic childhood illness, afflicting about 6.2 million children
in the United States. However, asthma could be better managed by identifying and avoiding triggers,
educating about medications and proper disease management strategies. This research utilizes
deep learning methodologies to predict asthma-related emergency department (ED) visit within 3
months using Medicaid claims data. We compare prediction results against traditional statistical
classification model - penalized Lasso logistic regression, which we trained and have deployed since
2015. The results have indicated that deep learning model Artificial Neural Networks (ANN) slightly
outperforms (with AUC = 0.845) the Lasso logistic regression (with AUC = 0.842). The reason may
come from the nonlinear nature of ANN.
Keywords Pediatric Asthma · Emergency Department Visit · Administrative Claims Data · Deep Learning · Predictive
Analytics · ANN
1 Introduction
More than 25 million Americans have asthma, which affects 7.7% of adults and 8.4% of children [6]. Asthma has been
increasing since the early 1980s in all age, sex and racial groups. Currently, asthma afflicts about 6.2 million children
under the age of 18 in the United States [34], rendering it the leading chronic childhood illness. Asthma accounts for 9.8
million doctor’s office visits, 188, 968 discharges from hospital inpatient care and 1.8 million emergency department
(ED) visits each year [7]. From 2008 to 2013, the annual economic cost of asthma was more than $81.9 billion,
including $50.3 billion medical costs [23]. The median annual medical cost of asthma was $983 per child in 2012, with
a range of $833 in Arizona to $1, 121 in Michigan [22]. Asthma disproportionately affects low-income, minority and
Medicaid-insured children, causing increased condition issues [25]. There is no cure to asthma, but studies reveal that
it can be managed with proper disease management and adequate medical treatment, which can effectively improve
asthma-related outcomes and reduce health care costs [15, 17].
Asthma is an ambulatory care-sensitive condition and most exacerbations that lead to ED visits or hospitalizations are
avoidable [9]. Timely identification of high risk asthma patients and proactive interventions are the key to improving
asthma care in the long-term. Risk factors for asthma-related adverse events have been extensively studied and multi-
factorial risk predictive models are playing an increasingly recognized role in optimizing value by focusing asthma care
on those at greatest risk [1, 31]. These models are mostly trained as traditional statistical models, including logistic
regressions, k-nearest meighbors, decision trees and support vector machines [10].
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Parkland Center for Clinical Innovation (PCCI) has developed a Lasso logistic regression model in 2015 to predict
asthma ED visit in the following 3 months for children under 18 years old, using clinical, health services utilization and
socio-demographic variables from Medicaid claims data. Compared to the published predictive models, our model has
higher clinical relevance [33], shows decent predictive accuracy [12], is derived from relatively large populations [28],
and is well-evaluated [2]. We have been sending monthly alert reports to providers, which contain information of
predicted high risk asthma patients, as well as inserting the Best Practice Alert (BPA) into Epic system, aiming to
reduce unnecessary hospital utilization and cost, increase patient adherence to medication and clinic visit, and improve
overall health care experience.
In this research, we continued to focus on Medicaid pediatric patients from Parkland Community Health Plan (PCHP), a
Medicaid health management organization (HMO) in north Texas, who provided us with the study setting. Our primary
goal was to utilize administrative claims data for a Medicaid-enrolled pediatric patient population to train and test deep
learning predictive models for forecasting the risk of asthma-related ED visits or hospitalizations within the next 3
months and to evaluate if the emerging deep learning models could outperform the current Lasso logistic regression
already in practice by comparing their predictive power. Our Lasso logistic regression model served as the baseline
benchmark against which deep learning model results would be compared. To the best of our knowledge, this approach
for this particular use case leveraging administrative claims data has not been attempted before.
2 Background
By the Council of State of Territorial Epidemiologists (CSTE) definition, a patient has “probable" asthma if s/he had
at least one ED visit or hospitalization or outpatient visit with a primary diagnosis of asthma, or at least one asthma
medication prescription in the preceding 12 months [32]. We used this CSTE standard to identify our original cohort
population in this study.
Health systems and clinicians have relied on traditional reporting tools for asthma case management and risk assessment
to imporve care quality. The Healthcare Effectiveness Data and Information Set (HEDIS) definition for persistent
asthma is a commonly used set of criteria [4, 13, 21], which is a combination checking of a patient’s asthma-related
ED visit, hospitalization and outpatient visit, as well as asthma medication dispensing events. We refer to [32] for
detailed medication prescription criteria. Note that HEDIS persistent asthma definition is a stronger condition than
CSTE “probable" asthma definition. The asthma medication ratio (AMR) also enjoys wide usage in identifying high
risk asthma patients [2, 5], which is defined as follows:
AMR =
number of controller prescription fills
number of controller prescription fills + number of reliver prescription fills
.
An AMR < 0.5 is usually associated with higher risk of patients ending up in the hospital with an acute asthma
exacerbation in the following several months [2, 29, 30]. Both HEDIS and AMR criteria are typically computed from a
12-month time cycle. And neither of them addresses the socio-demographic or comorbidities factors.
PCCI’s Lasso logistic regression model is robust and clinically relevant, which significantly outperforms both HEDIS
persistent asthma case-definition criteria and AMR< 0.5 clinical criteria in the predictive power to classify high risk
patients.
3 Methodology
Deep learning models identifies intricate structure in large data sets [19] through multiple layers in the neural network
architectures that learn directly from the data without the need for manual feature extraction. Health care stands to
benefit immensely from deep learning technologies because of the data volume, as well as the emerging unstructured
complex types of data including electronic health records (EHR), imaging and text data [11, 20]. Recently various
deep learning models have been extensively applied to different subfields in health care and have achieved great
advancements [3, 18, 24, 26, 27].
3.1 Data and Features
Claims data consists of billing codes that health care providers and facilities submit to payers. It follows a consistent
format and uses a standard set of pre-established codes that describe specific diagnosis, procedures, medications, as
well as billed and paid amounts [16]. Additionally, claims data documents nearly all interactions a patient has across all
the health care systems. Claims data captures broader information for patients and provides access to larger and more
diverse patient cohort. However, claims data has, by its nature, a time lag of about 30 to 90 days due to the processing
time before it is finally added to the database and becomes available for analysis use.
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Figure 1: Asthma cohort selection process
In order to compare with our baseline model in production, the data for this study was extracted from PCHP claims
data between July 2012 and June 2014, which was the same time range as the one we used to train the Lasso logistic
regression model. We first filtered for children aged between 6 months and 18 years old at prediction time and applied
CSTE “probable” asthma criteria to identify original cohort. To be included in the model cohort, we further checked
that the patient was enrolled in PCHP continually in our study time range. The size of the final data set was reduced to
28, 378 unique patients. And the prevalence rate for patients with asthma ED visits in the following 3 months was about
3%. The Figure 1 illustrates and summarizes the cohort selection process for our study.
The features generated from claims data for predictive model could be broadly classified into five categories, as shown
in the Table 3.1. Considering the inherent 30-day time lag in PCHP claims data, we excluded the features that were
highly likely to be incorrectly coded, for example the ED visit number in the past month at prediction time. After this
feature pre-selection step, we had in total 33 features.
Category Example features
Demographics Gender, age
Medication AMR, controller medication dispensation events, reliever medication dispensation events
Health service utilization Number of asthma-related ED visits in the past 3, 6, 12 months
Comorbid illinesses Obesity, sleep apnea
Insurance gap Number of insurance gaps in the past 12 months
Table 3.1: Model features in broader categories
3.2 Methods
Artificial Neural Networks are inspired by biological neural networks, which are based on a family of interconnected
units, called artificial neurons. Each connection can receive a signal from artificial neurons as an input, change the
internal state and transmit the output to another artificial neurons connected to it. ANNs could learn and model complex
nonlinear relationships in the data sets [8]. The feedforward networks are used in our study and the model structure is
shown in the Figure 2. The input layer consists of all the predictors that were previously validated and normalized when
necessary. The hidden layer applies the activation function to the weighted sum of input layers and forward passes the
results to the next layer. In the final output layer, the sigmoid activation function is used to produce a probability for our
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Figure 2: ANN connection in our model
desired binary outcome. We define the loss function and backpropagate the error to hidden layers to update the weights.
We iterate this process until the predefined convergence rate is achieved.
3.3 Training and Test Strategies
Data was randomly divided into training and test sets in 0.7/0.3 proportions. We applied various resampling methods
to obtain different training samples − original training data, oversampled data and downsampled data. We applied
dropout regularization technique to avoid overfitting. Considering the size of the data set, we only used two hidden
layers as one hidden layer are usually sufficient for most classification problems and too many hidden layers could
easily cause overfitting [14]. The model was trained using Keras library in Python 3.7 and the Table 3.3 shows our best
hyperparameter selection of the ANN model.
Parameters Selection
Loss function Binary cross-entropy
Optimizer Adam
Activation function Leaky ReLU (α = 0.1) and Sigmoid
Batch size 32
Epochs 100
Dropout (recurrent dropout) 0.5
Learning rate 0.01
Table 3.2: Hyperparameter selection in ANN model
4 Results and Discussion
We provided the following statistical metrics from the test data to evaluate and compare the classification power between
ANN model and Lasso logistic regression model: the area under the Receiver Operating Characteristic curve (ROC
AUC, C-statistic), recall, precision, F1 score and the area under precision-recall curve (PR AUC). Here F1 score is
defined as F1 =
2 · precision · recall
precision + recall
. Due to the significant imbalance in the test data, we didn’t utilize prediction
accuracy to assess model performance. Based on the prevalence rate of actual adverse events, model performance
4
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Figure 3: ROC curve and PR curve of ANN
metrics and clinical assessment of the likely capacity of a potential intervention program, we designed the patients in
the top most 10 percent of risk scores as “High", the 10th to 20th percentile range as “Medium” and the rest as “Low”
risk in the Lasso logistic regression model. We kept the same thresholds for ANN model. The predicted adverse events
were only from “High” risk category. Results from proposed models are shown in the Table 4 and the Figure 3. Larger
areas from both ROC curve and PR curve for ANN model indicated that it outperformed the Lasso logistic regression in
classification power. However, lower F1 reminded us that we need to re-adjust our thresholds for ANN model.
Models ROC AUC Recall Precision F1 score PR AUC
Lasso logistic regression 0.842 0.565 0.123 0.202 0.170
ANN 0.845 0.510 0.123 0.198 0.174
Table 4.1: Evaluation metrics for model performance
5 Conclusion
With the exact same data set and initial feature list, ANN model only produced slightly higher statistical classification
power than the Lasso logistic regression. This is consistent with the results from [10] to compare logistic regression
and ANN models in multiple medical data classification tasks. This study further confirmed that the Lasso logistic
regression model developed by PCCI in 2015 could produce desirable statistical performance that is non-inferior to
deep learning models which are more difficult to interpret. And in order for our predictive models to be deployed and
effectively improve patient care, we need to work closely with clinicians to explain predictions in comprehensive and
interpretable formats to build trust and transparency with stakeholders.
For future studies, blender algorithms would be tested against other singular models to achieve better statistical
performances. We would explore the temporal relationships in claims data using other deep learning models, like
Recurrent Neural Networks (RNN) and Long Short-Term Memory (LSTM). In order to get more timely and accurate
patient information, we could link EHR data, which is longitudinal in nature, with claims data. We could also combine
Social Determinants of Health (SDoH) data with claims data, to analyze how it contributes to the outcome. We would
continue validating our model using the most recent available claims data and retrain the model if necessary to capture
more accurate characteristics of our cohort populations.
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